Migliaccio Antimo, Castoria Gabriella, Auricchio Ferdinando
Dipartimento di Patologia Generale, II Universita'di Napoli, Napoli, Italy.
Methods Mol Biol. 2011;776:361-70. doi: 10.1007/978-1-61779-243-4_21.
Much evidence indicates that, with few exceptions, non-genomic actions of steroids are mediated by receptors universally known as nuclear receptors. Steroid receptors do not exhibit intrinsic tyrosine kinase activity. Nevertheless, they stimulate different signaling pathways in cytoplasm of target cells, including those dependent on Src, a cytoplasmic tyrosine kinase. Steroid-induced Src activation regulates cell cycle progression, survival, migration, and associated processes, such as cell growth and differentiation. Androgen stimulation of human prostate cancer-derived LNCaP cells triggers cell cycle progression and proliferation. The key event in this process is the association of androgen receptor (AR) with Src. This association triggers activation of the Src/Ras/Erk pathway and finally impacts cell cycle. Androgen stimulation of fibroblasts also induces AR/Src association, which triggers DNA synthesis. Prevention of this association by a receptor-derived peptide competing for AR interaction with Src specifically inhibits the androgen receptor-dependent proliferative effect in vitro and in vivo.
大量证据表明,除少数例外情况外,类固醇的非基因组作用是由普遍称为核受体的受体介导的。类固醇受体不表现出内在的酪氨酸激酶活性。然而,它们会刺激靶细胞细胞质中的不同信号通路,包括那些依赖于细胞质酪氨酸激酶Src的信号通路。类固醇诱导的Src激活调节细胞周期进程、存活、迁移以及相关过程,如细胞生长和分化。雄激素对人前列腺癌来源的LNCaP细胞的刺激会触发细胞周期进程和增殖。这个过程中的关键事件是雄激素受体(AR)与Src的结合。这种结合会触发Src/Ras/Erk通路的激活,最终影响细胞周期。雄激素对成纤维细胞的刺激也会诱导AR/Src结合,从而触发DNA合成。通过一种受体衍生肽竞争AR与Src的相互作用来阻止这种结合,可在体外和体内特异性抑制雄激素受体依赖性增殖效应。